Lung cancer: treatment pathway in the radiotherapy department at the National Oncology Institute of Rabat
Lachgar, A.; Sahli, N.; Toulba, A.; Kebdani, T.; Benjaafar, N.
Pan African medical journal 21: 253
2015
ISSN/ISBN: 1937-8688 PMID: 26523190 DOI: 10.11604/pamj.2015.21.253.6627Document Number: 249176
Document emailed within 0-6 h
Related Documents
Hoyt, D.B.; Holcomb, J.; Abraham, E.; Atkins, J.; Sopko, G. 2004: Working Group on Trauma Research Program summary report: National Heart Lung Blood Institute (NHLBI), National Institute of General Medical Sciences (NIGMS), and National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH), and the Department of Defense (DOD) Journal of trauma 57(2): 410-415Radomski, P.; Słodkowska, J.; Wiatr, E.; Remiszewski, P.; Androsiuk, W.; Rowińska-Zakrzewska, E. 1998: The pattern of small cell lung carcinoma in autopsy (based on material of the Pathology Department, National Institute of Tuberculosis and Lung Diseases in Warsaw Pneumonologia i alergologia polska 66(11-12): 536-544
Chabner, B.A.; Curt, G.A.; Hubbard, S.M. 1984: Surgical oncology research development: the perspective of the National Cancer Institute Cancer Treatment Reports 68(6): 825-829
Hillman, B.J. 1997: Report of the Department of Defense, National Cancer Institute, Department of Health and Human Services Office of Women's Health workshop on the mobile breast care center Academic Radiology 4(6): 451-457
de Castro Silva, S.Luís.Freire.; Gonçalves, Aônio.Augusto.; Martins, C.Henrique.Fernandes.; Cheng, C.; Barbosa, Jé.Geraldo.Pereira.; de Oliveira, S.Barbará. 2018: Smart Oncology Care Networks: An Approach in Information Systems to Support Brazilian National Cancer Institute Studies in Health Technology and Informatics 251: 195-198
Beltrán-Ortega, A.; Ramírez-Ugalde, M.T.; Mora-Tiscareño, A. 1978: Combination of surgery and immunotherapy in the treatment of melanoma. Experience of the National Institute of Oncology Gaceta Medica de Mexico 114(1): 29-36
Greco, C.; Castiglioni, S.; Fodor, A.; Mazzetta, C.; De Cobelli, O.; Orecchia, R. 2004: Androgen ablation therapy does not increase the risk of late morbidity following 3D-conformal radiotherapy of organ-confined prostate cancer: the experience of the European Institute of Oncology Tumori 90(6): 567-572
Manafu, E.Gabriela.; Filimon, R.Mihaela.; Jari, I.; Petrariu, F.D.; Manole, A. 2014: Clinical epidemiological study on the incidence of Escherichia coli infections in the cancer patients admitted to Surgery Department II of the Iasi Regional Oncology Institute in 2013 Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 118(3): 796-800
Low, J.Sh.; Koh, W.Yao.; Yap, S.Peng.; Fong, K.Weng. 2007: Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience Annals of the Academy of Medicine Singapore 36(9): 778-783
Rose, V.L. 1998: National Heart, Lung, and Blood Institute releases new guidelines for the treatment of hypertension American Family Physician 57(2): 362-4 366
Shtern, F. 1998: Mobile Breast Care Center: a joint program of the Department of Defense, U.S. Public Health Service's Office on Women's Health, and the National Cancer Institute Academic Radiology 5 Suppl. 2: S409-S410
1960: SELECTED list of research training programs supported by the National Heart Institute, National Institutes of Health, Public Health Service, Department of Health, Education and Welfare Circulation 21(3)pt2: 1-15
Niitani, H.; Fukuoka, M.; Furuse, K.; Kudoh, S.; Kurita, Y.; Ohnoshi, T.; Saijoh, N. 1997: New drugs for the treatment of lung cancer. the Tokyo Cooperative Oncology Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 1): 117-119
Plasswilm, L. 2000: Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer or head and neck cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(12): 583-584
Shepherd, F.A. 2001: Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer Seminars in Oncology 28(2 Suppl 4: 30-37
Benderli Cihan, Y. 2018: Role of mTOR signaling pathway proteins and proteins influencing mTOR pathway in resistance to radiotherapy in prostate cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 23(6): 1931-1932
Wang, Y-jie.; Wang, Lü-hua.; Lü, J-ma.; Zhao, L-jun.; Xiao, Z-fen.; Zhang, H-xing.; Feng, Q-fu.; Zhang, Z.; Yin, W-bo. 2006: Three-dimensional conformal radiotherapy for locoregionally recurrent non-small cell lung cancer after initial radiotherapy Zhonghua Zhong Liu Za Zhi 28(3): 227-229
McCracken, J.D.; Janaki, L.M.; Taylor, S.B.; Giri, P.G.; Weiss, G.B.; Gordon, W.; Vance, R.B.; Crowley, J. 1986: Concurrent chemotherapy and radiotherapy for limited small-cell carcinoma of the lung: a Southwest Oncology Group Study Seminars in Oncology 13(3 Suppl 3: 31-36
Zeng, P.; Yin, L.; Luo, B.; Liu, Z.; Jin, X. 1998: VP-16 and VM-26 plus platinum drugs combined with radiotherapy in the treatment of small cell lung cancer Hunan Yi Ke da Xue Xue Bao 23(6): 587-589
Wolf, M.; Hans, K.; Becker, H.; Hässler, R.; von Bültzingslöwen, F.; Goerg, R.; Klaasen, H.A.; Dannhäuser, J.; Holle, R.; Pfab, R. 1994: Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 42-47